Considerations To Know About ABBV-744 BRD4 inhibitor cancer therapy efficacy
In Section C, participants will acquire ABBV-744 and oral navitoclax. In Segment D, individuals will acquire ABBV-744 and ruxolitinib. Participants will get treatment until sickness progression or perhaps the contributors are unable to tolerate the study drugs.Celastrol was identified as being a Myb inhibitor that suppressed C/EBPβ activity and re